{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T07:25:59Z","timestamp":1779002759852,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute of Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000272","name":"NHS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Royal Melbourne Hospital Foundation Lottery Grants"},{"DOI":"10.13039\/100004098","name":"RMH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.eplepsyres.2014.08.022","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T11:14:45Z","timestamp":1410866085000},"page":"1797-1805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Validation of a multigenic model to predict seizure control in newly treated epilepsy"],"prefix":"10.1016","volume":"108","author":[{"given":"Kanvel","family":"Shazadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Slav\u00e9","family":"Petrovski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie","family":"Roten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard M.","family":"Huggins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin J.","family":"Brodie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munir","family":"Pirmohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony G.","family":"Marson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence J.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme J.","family":"Sills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0005","first-page":"1353","article-title":"Computer-assisted pattern recognition of autoantibody results","volume":"12","author":"Binder","year":"2005","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0010","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2217\/pgs.11.85","article-title":"Pharmacogenomics and epilepsy: the road ahead","volume":"12","author":"Cavalleri","year":"2011","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0015","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ana.22502","article-title":"Pharmacogenomics in neurology: current state and future steps","volume":"70","author":"Chan","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0020","series-title":"Methods of Microarray Data Analysis","first-page":"191","article-title":"Higher dimensional approach for classification of lung cancer microarray data","author":"Crimins","year":"2005"},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0025","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0140-6736(06)68477-8","article-title":"Adult epilepsy","volume":"367","author":"Duncan","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0030","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2307\/1403797","article-title":"Discriminatory analysis\u2014nonparametric discrimination: consistency properties","volume":"57","author":"Fix","year":"1989","journal-title":"Int. Stat. Rev."},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0035","article-title":"SNP genotyping using the Sequenom MassARRAY iPLEX platform","volume":"60","author":"Gabriel","year":"2009","journal-title":"Curr. Protoc. Hum. Genet. Supplement"},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0040","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMp0806284","article-title":"Common genetic variation and human traits","volume":"360","author":"Goldstein","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0045","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2217\/pgs.10.62","article-title":"Genetic profile of patients with epilepsy on first-line antiepileptic drugs and potential directions for personalized treatment","volume":"11","author":"Grover","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0050","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.2217\/pgs.12.127","article-title":"SCN1A IVS5N+5 polymorphism and response to sodium valproate: a multicenter study","volume":"13","author":"Haerian","year":"2012","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0055","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2217\/pgs.11.143","article-title":"Lack of association between ABCC2 gene variants and treatment response in epilepsy","volume":"13","author":"Hilger","year":"2012","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0060","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJMp0808934","article-title":"Genome wide association studies\u2014illuminating biologic pathways","volume":"360","author":"Hirschhorn","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.yebeh.2011.02.012","article-title":"Newly diagnosed epilepsy and pharmacogenomics research: a step in the right direction?","volume":"22","author":"Johnson","year":"2011","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0070","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1101\/gr.229102","article-title":"The human genome browser at UCSC","volume":"12","author":"Kent","year":"2002","journal-title":"Genome Res."},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0075","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1471-2105-5-160","article-title":"Reuse of imputed data in microarray analysis increases imputation efficiency","volume":"5","author":"Kim","year":"2004","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0080","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1056\/NEJMp0810107","article-title":"Genetic risk prediction\u2014are we there yet?","volume":"360","author":"Kraft","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0085","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0090","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0095","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S1474-4422(06)70500-2","article-title":"Clinical factors and ABCB1 polymorphisms in prediction of antiepileptic drug response: a prospective cohort study","volume":"5","author":"Leschziner","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0100","doi-asserted-by":"crossref","DOI":"10.4061\/2009\/484351","article-title":"Prediction of disease severity in patients with early rheumatoid arthritis by gene expression profiling","author":"Liu","year":"2009","journal-title":"Hum. Genomics Proteomics"},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0105","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1111\/j.1528-1167.2011.03097.x","article-title":"A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy","volume":"52","author":"Manna","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0110","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(07)60460-7","article-title":"The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0115","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","article-title":"The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0120","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2217\/14622416.7.7.1003","article-title":"Toxicogenomics strategies for predicting drug toxicity","volume":"7","author":"Martin","year":"2006","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0125","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/bioinformatics\/btp331","article-title":"Predictor correlation impacts machine learning algorithms: implications for genomic studies","volume":"25","author":"Nicodemus","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/FPC.0b013e32831d1dfa","article-title":"Multi-SNP pharmacogenomic classifier is superior to single-SNP models for predicting drug outcome in complex diseases","volume":"19","author":"Petrovski","year":"2009","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.seizure.2009.12.004","article-title":"Genetic factors associated with drug-resistance of epilepsy: relevance of stratification by patient age and aetiology of epilepsy","volume":"19","author":"S\u00e1nchez","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0140","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1056\/NEJMoa021986","article-title":"Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1","volume":"348","author":"Siddiqui","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0145","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1528-1167.2009.02059.x","article-title":"Multidrug-resistant genotype (ABCB1) and seizure recurrence in newly treated epilepsy: data from international pharmacogenetic cohorts","volume":"50","author":"Szoeke","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0150","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s004240050783","article-title":"Molecular and functional characterization of s-KCNQ1 potassium channel from rectal gland of Squalus acanthias","volume":"437","author":"Waldegger","year":"1999","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0155","doi-asserted-by":"crossref","first-page":"7577","DOI":"10.1523\/JNEUROSCI.23-20-07577.2003","article-title":"Sodium channel beta4, a new disulfide-linked auxiliary subunit with similarity to beta2","volume":"23","author":"Yu","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2014.08.022_bib0160","doi-asserted-by":"crossref","first-page":"W635","DOI":"10.1093\/nar\/gkl236","article-title":"FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization","volume":"34","author":"Yuan","year":"2006","journal-title":"Nucleic Acids Res."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121114002319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121114002319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:32:58Z","timestamp":1760275978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121114002319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0920121114002319"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2014.08.022","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of a multigenic model to predict seizure control in newly treated epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2014.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}